Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ciara N. Schwarz"'
Autor:
Won Jong Jin, Amy K. Erbe, Ciara N. Schwarz, Abigail A. Jaquish, Bryce R. Anderson, Raghava N. Sriramaneni, Justin C. Jagodinsky, Amber M. Bates, Paul A. Clark, Trang Le, Keng-Hsueh Lan, Yi Chen, KyungMann Kim, Zachary S. Morris
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
In head and neck squamous cell carcinoma (HNSCC) tumors that over-expresses huEGFR, the anti-EGFR antibody, cetuximab, antagonizes tumor cell viability and sensitizes to radiation therapy. However, the immunologic interactions between cetuximab and r
Externí odkaz:
https://doaj.org/article/cb1c402282874fdc932a12949b4cd965
Autor:
Claire C. Baniel, Clinton M. Heinze, Anna Hoefges, Elizabeth G. Sumiec, Jaquelyn A. Hank, Peter M. Carlson, Won Jong Jin, Ravi B. Patel, Raghava N. Sriramaneni, Stephen D. Gillies, Amy K. Erbe, Ciara N. Schwarz, Alexander A. Pieper, Alexander L. Rakhmilevich, Paul M. Sondel, Zachary S. Morris
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
In a syngeneic murine melanoma (MEL) model, we recently reported an in situ vaccination response to combined radiation (RT) and intra-tumoral (IT) injection of anti-GD2 hu14. 18-IL2 immunocytokine (IC). This combined treatment resulted in 71% complet
Externí odkaz:
https://doaj.org/article/69d352c38672413f9676b26e4741f6de
Autor:
Zachary S. Morris, Amber M. Bates, Justin C. Jagodinsky, Won Jong Jin, Bryce R. Anderson, Ciara N. Schwarz, Abigail A Jaquish, Raghava N. Sriramaneni, Yi Chen, Keng-Hsueh Lan, Trang T. Le, KyungMann Kim, Amy K. Erbe, Paul A. Clark
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology
Frontiers in Immunology
In head and neck squamous cell carcinoma (HNSCC) tumors that over-expresses huEGFR, the anti-EGFR antibody, cetuximab, antagonizes tumor cell viability and sensitizes to radiation therapy. However, the immunologic interactions between cetuximab and r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdd2d1baeca870880057a66c84ee6b1c
https://www.frontiersin.org/articles/10.3389/fimmu.2020.591139/full
https://www.frontiersin.org/articles/10.3389/fimmu.2020.591139/full
Autor:
Paul A. Clark, Abigail A Jaquish, Zachary S. Morris, Wonjong Jin, Amy K. Erbe, Justin C. Jagodinsky, Ciara N. Schwarz, Bryce R. Anderson, Raghava N. Sriramaneni
Publikováno v:
Cancer Research. 80:1881-1881
Purpose: Patients with head and neck squamous cell carcinoma (HNSCC) treated with anti-EGFR (cetuximab) mAb-based immunotherapy often acquire therapy-resistance, reducing clinical benefit. We evaluated the efficacy of a combined modality in situ vacc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::393b592793021c52631322642d34e7b0
https://doi.org/10.1158/1538-7445.am2020-1881
https://doi.org/10.1158/1538-7445.am2020-1881